Lumos Pharma Inc. | Betriebsaufwand

Name: Lumos Pharma Inc. | Betriebsaufwand
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Operating Expenses		Datum
Agenus AGEN:US	$ 65.49M	4.09M	2022-06
Bristol Myers Squibb BMY:US	$ 9.3B	202M	2022-06
Capricor Therapeutics CAPR:US	$ 7.32M	509.78K	2022-06
Celldex Therapeutics CLDX:US	$ 36.56M	13.13M	2022-06
Eli Lilly And LLY:US	$ 5277.9M	127.8M	2022-06
Idera Pharmaceuticals IDRA:US	$ 5.36M	1.18M	2022-06
Intrexon XON:US	$ 27.07M	22.84M	2022-06
Merk MRK:US	$ 9666M	666M	2022-06
Nektar Therapeutics NKTR:US	$ 174.42M	33.04M	2022-06
Newlink Genetics NLNK:US	8.33M	485K	2022-06
Pfizer PFE:US	$ 15640M	148M	2022-06
Prothena PRTA:US	44.52M	5.42M	2022-06
Sarepta Therapeutics SRPT:US	$ 444.62M	146.91M	2022-06
Vascular Biogenics VBLT:US	9.68M	999K	2022-06
YTE INCY:US	$ 656.97M	40.27M	2022-06

Lumos Pharma Inc. Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.